| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/13/2010 | EP2142176A1 Compositions and methods for transmucosal delivery of domperidone |
| 01/13/2010 | EP2142175A2 Pharmaceutical compositions of diclofenac and misoprostol |
| 01/13/2010 | EP2142173A1 High dose composition of ursodeoxycholic acid |
| 01/13/2010 | EP2142169A2 Aqueous pharmaceutical preparation |
| 01/13/2010 | EP2141995A1 Compositions and methods for protecting cells from toxic exposures |
| 01/13/2010 | EP2141994A1 Multi-ring compounds and uses thereof |
| 01/13/2010 | EP2141990A1 11beta-hsd1 active compounds |
| 01/13/2010 | EP2141989A1 Compositions and methods for prophylaxis and treatment of addictions |
| 01/13/2010 | EP2063877B1 Drugs comprising at inhibitor of class i alpha mannosidase for the treatment of sarcoglycanopathies |
| 01/13/2010 | EP2035385B1 Inhibitors of akt (protein kinase b) |
| 01/13/2010 | EP2027108B1 Histamine receptor antagonists comprising an azepin core |
| 01/13/2010 | EP2021337B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/13/2010 | EP1987029B1 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands |
| 01/13/2010 | EP1924558B1 An antimalarial baylis-hillman adducts and a process for the preparation thereof |
| 01/13/2010 | EP1910298B1 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
| 01/13/2010 | EP1869018B1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands |
| 01/13/2010 | EP1778622B1 Para-alkyl-substituted n-(4-hydroxy-3-methoxy-benzyl) cinnamamides and the use thereof for producing drugs |
| 01/13/2010 | EP1758851B1 Vanilloid trpv1 receptor antagonists |
| 01/13/2010 | EP1753747B1 5,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agents |
| 01/13/2010 | EP1682144B1 Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties |
| 01/13/2010 | EP1660095B1 Tricyclic parp inhibitors |
| 01/13/2010 | EP1641805B1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 01/13/2010 | EP1594884B1 Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates |
| 01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 01/13/2010 | EP1556486B1 Effective and stable dna enzymes |
| 01/13/2010 | EP1487453B1 N- ¬(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl methyl -2- 3-¬(methylsulphonyl)amino phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1451160B1 Pyrazole-amides for use in the treatment of pain |
| 01/13/2010 | EP1435954B1 A PROCESS FOR THE PREPARATION OF HIGHlLY PUREAMLODIPINE BENZENESULFONATE |
| 01/13/2010 | EP1422229B1 Porphyrin-metal complexes and oxygen infusions containing the same |
| 01/13/2010 | EP1406910B1 Preparation methods of derivatives of bisphosphonates |
| 01/13/2010 | EP1399414B1 Substituted tetracycline compounds for the treatment of malaria |
| 01/13/2010 | EP1323415B1 Method of coating fine particle with lipid film |
| 01/13/2010 | EP1255725B1 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 01/13/2010 | EP1211242B1 Prostaglandin derivatives |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | EP0969838B2 Controlled release compositions for the treatment of hyperlipidemia |
| 01/13/2010 | CN201379811Y Muscle and bone plaster |
| 01/13/2010 | CN101626771A Therapeutic agent for meniere's disease |
| 01/13/2010 | CN101626770A Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release |
| 01/13/2010 | CN101626769A Pellets comprising an active substance matrix and a polymer coating, and a method for producing said pellets |
| 01/13/2010 | CN101626768A Synthesis, methods of using, and compositions of cycloalkylmethylamines |
| 01/13/2010 | CN101626767A Heterocyclic inhibitors of MEK and methods of use thereof |
| 01/13/2010 | CN101626766A Improvements in and relating to medicinal compositions |
| 01/13/2010 | CN101626765A Transcription factor modulating compounds and methods of use thereof |
| 01/13/2010 | CN101626764A Amino acid composition |
| 01/13/2010 | CN101626763A Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors |
| 01/13/2010 | CN101626762A Solvating system and sealant for medical use |
| 01/13/2010 | CN101626761A Device for the transdermal administration of bisoprolol |
| 01/13/2010 | CN101626760A Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
| 01/13/2010 | CN101626759A Methods, compositions, and formulations for the treatment of thyroid eye disease |
| 01/13/2010 | CN101626758A Combinations of therapeutic agents for treating cancer |
| 01/13/2010 | CN101624391A Thiophene derivatives as antiviral agents for flavivirus infection |
| 01/13/2010 | CN101624372A Lactam compound |
| 01/13/2010 | CN101623296A Antimalarial green tea chewing gum |
| 01/13/2010 | CN101623295A Medicine for treating bladder neoplasms |
| 01/13/2010 | CN101623294A Composition for reducing blood pressure |
| 01/13/2010 | CN101623293A Medical composition for injection |
| 01/13/2010 | CN101623292A Multi-unit bowel dissolvable preparation of compound alendronate sodium and vitamin D3 and preparation method thereof |
| 01/13/2010 | CN101623291A Dexamethasone sodium phosphate injection |
| 01/13/2010 | CN101623290A Drospirenone analogue medicinal composition |
| 01/13/2010 | CN101623289A Novel drospirenone analogue medicinal composition |
| 01/13/2010 | CN101623288A Medicinal composition containing drospirenone analogue for treating menopausal syndrome |
| 01/13/2010 | CN101623287A Novel drospirenone analogue medicinal composition for treating menopausal syndrome |
| 01/13/2010 | CN101623286A Transdermal administration composite containing cucurbitacin-type active ingredient |
| 01/13/2010 | CN101623285A Cefmetazole sodium medicament and preparation method thereof |
| 01/13/2010 | CN101623284A Medical composition of compound vitamin C injection |
| 01/13/2010 | CN101623283A Medicinal composition for relieving asthma |
| 01/13/2010 | CN101623282A Aspirin-dipyridomole sustained-release capsule and preparation method thereof |
| 01/13/2010 | CN101623281A Application of cetirizine hydrochloride in preparation of medicine for treating pruritus caused by fungi |
| 01/13/2010 | CN101623280A Compound sustained release preparation for easing pain and preparation method thereof |
| 01/13/2010 | CN101623279A Medicinal composition containing felodipine and metoprolol |
| 01/13/2010 | CN101623278A Medicinal composition containing levodopa and benserazide hydrochloride |
| 01/13/2010 | CN101623277A Suwei A amine, novel application of active derivative and medicine composition thereof |
| 01/13/2010 | CN101623274A Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 01/13/2010 | CN100580005C Method of preparing carboxylic acid functionalized polymers |
| 01/13/2010 | CN100579998C Oral-use polymer and oral-use composition |
| 01/13/2010 | CN100579981C 3,9-dioxaasterane compounds and preparation method and application thereof |
| 01/13/2010 | CN100579980C Ru(II) complex with anticancer liveness and method for preparing the same |
| 01/13/2010 | CN100579979C 7-phenylpyrazolopyridine compounds |
| 01/13/2010 | CN100579978C Compounds |
| 01/13/2010 | CN100579977C Method for producing antifungal drug in triazole class |
| 01/13/2010 | CN100579976C P38 inhibitors and methods of use thereof |
| 01/13/2010 | CN100579975C Process for preparing duloxetine and intermediates for use therein |
| 01/13/2010 | CN100579968C Quinazolinone derivatives and their use as CB agonists |
| 01/13/2010 | CN100579966C Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof |
| 01/13/2010 | CN100579963C Process for the preparation of N-amino substituted heterocyclic compounds |
| 01/13/2010 | CN100579957C Novel arylamidine derivative or salt thereof |
| 01/13/2010 | CN100579606C Use of whey permeate for the treatment of metabolic syndrome |
| 01/13/2010 | CN100579579C Anti-cancer and anti-infectious disease compositions and methods for using same |
| 01/13/2010 | CN100579571C Car sickness preventing and treating beverage |
| 01/13/2010 | CN100579540C Medicine compound for preventing and treating gynecopathy such as pelvic inflammatory disease |
| 01/13/2010 | CN100579538C Compound spray for treating rhinitis and preparation method thereof |
| 01/13/2010 | CN100579534C Application of S-adenyhomotype cysteine in medical preparation |
| 01/13/2010 | CN100579533C Compounds for the treatment of pain |
| 01/13/2010 | CN100579532C Florfenicol prodrug having improved water solubility |
| 01/13/2010 | CN100579531C Medicine composition for treating psoriasis |
| 01/13/2010 | CN100579530C Stabilized compositions comprising therapeutically active agent, citric acid or conjugated base and chlorine dioxide |
| 01/13/2010 | CN100579529C Alprostadil freeze-dried emulsion and its preparation method |
| 01/13/2010 | CN100579528C Dispersion tablet for improving brain circulation |